mitotane has been researched along with Cancer of Prostate in 3 studies
Mitotane: A derivative of the insecticide DICHLORODIPHENYLDICHLOROETHANE that specifically inhibits cells of the adrenal cortex and their production of hormones. It is used to treat adrenocortical tumors and causes CNS damage, but no bone marrow depression.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (66.67) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Raja Gabaglia, C | 1 |
Diaz de Durana, Y | 1 |
Graham, FL | 1 |
Gauldie, J | 1 |
Sercarz, EE | 1 |
Braciak, TA | 1 |
Matveeva, SA | 1 |
Barsel', VA | 1 |
Evseenko, LS | 1 |
Newmark, SR | 1 |
Dluhy, RG | 1 |
Bennett, AH | 1 |
3 other studies available for mitotane and Cancer of Prostate
Article | Year |
---|---|
Attenuation of the glucocorticoid response during Ad5IL-12 adenovirus vector treatment enhances natural killer cell-mediated killing of MHC class I-negative LNCaP prostate tumors.
Topics: Adenoviridae; Animals; Antineoplastic Agents, Hormonal; Combined Modality Therapy; Genes, MHC Class | 2007 |
[Change in the excretion of adrenal steroids as dependent on the chlodithane (2,4'-DDD) concentration in the blood of oncological patients].
Topics: 17-Hydroxycorticosteroids; 17-Ketosteroids; Adenocarcinoma; Adrenal Cortex Hormones; Adrenal Glands; | 1976 |
Ectopic adrenocorticotropin syndrome with prostatic carcinoma.
Topics: 17-Hydroxycorticosteroids; 17-Ketosteroids; Adenocarcinoma; Adrenocorticotropic Hormone; Blood Gluco | 1973 |